Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.56% | 2.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.56% | 2.67% | |||
| Cost of Revenue | 0.12% | -1.03% | |||
| Gross Profit | 6.70% | 6.29% | |||
| SG&A Expenses | -1.05% | 4.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.15% | 1.35% | |||
| Operating Income | 28.24% | 7.64% | |||
| Income Before Tax | 56.44% | 52.72% | |||
| Income Tax Expenses | 25.25% | -162.86% | |||
| Earnings from Continuing Operations | 59.61% | 59.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.61% | 59.86% | |||
| EBIT | 28.24% | 7.64% | |||
| EBITDA | 33.18% | 8.92% | |||
| EPS Basic | 59.96% | 60.25% | |||
| Normalized Basic EPS | 34.02% | -4.76% | |||
| EPS Diluted | 59.96% | 60.25% | |||
| Normalized Diluted EPS | 34.02% | -4.76% | |||
| Average Basic Shares Outstanding | 0.90% | 0.97% | |||
| Average Diluted Shares Outstanding | 0.90% | 0.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||